Finance

Lists
Why is ARTV down 2,45%?
Dive Deeper
ARTV:NASDAQ
Artiva Biotherapeutics Inc
6,77 USD
-2,45%
(-0,17) 1D
6,77 USD
0,00% (0,00)
After hours
Closed: 12-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
6,92 USD
High
6,94 USD
Low
6,73 USD
Mkt. cap
330,99 млн
Avg. vol.
456,17 миң
Volume
0,00
52-wk high
14,53 USD
52-wk low
2,71 USD
EPS
-3,31 USD
Shares outstanding
48,89 млн
No. of employees
115
Open
6,92 USD
High
6,94 USD
Low
6,73 USD
Mkt. cap
330,99 млн
Avg. vol.
456,17 миң
Volume
0,00
52-wk high
14,53 USD
52-wk low
2,71 USD
EPS
-3,31 USD
Shares outstanding
48,89 млн
No. of employees
115
News stories
From web sources and news partners
About Artiva Biotherapeutics Inc
CEO-
Employees115
Founded2019
Headquarters-
Sector-
Websiteartivabio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ARTV in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current 6,77 USD
41,00 USD (+505,61%)
Average
38,00 USD (+461,30%)
Lowest
35,00 USD (+416,99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gil Blum
Needham
Buy
Maintained
41,00 USD
+505,6%
10/01/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
35,00 USD
+417%
10/01/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
40,00 USD
+490,8%
05/25/2026
Unknown Analyst
Jefferies
Buy
Maintained
23,00 USD
+239,7%
05/21/2026
Martin Fan
Wedbush
Buy
Maintained
40,00 USD
+490,8%
05/21/2026
David Nierengarten
Wedbush
Buy
Maintained
40,00 USD
+490,8%
05/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17,63 млн
16,99 млн
19,31 млн
21,92 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,26 млн
4,94 млн
5,12 млн
4,96 млн
Operating expense
22,90 млн
21,93 млн
24,43 млн
26,89 млн
Total operating expenses
22,90 млн
21,93 млн
24,43 млн
26,89 млн
Operating income
-22,90 млн
-21,93 млн
-24,43 млн
-26,89 млн
Other non operating income
-3,00 миң
-1,88 млн
2,00 миң
-1,00 миң
EBT including unusual items
-21,53 млн
-20,77 млн
-23,52 млн
-25,00 млн
EBT excluding unusual items
-21,53 млн
-22,65 млн
-23,52 млн
-25,00 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21,53 млн
-20,77 млн
-23,52 млн
-25,00 млн
Net profit margin
-
-
-
-
Earnings per share
-0,88
-0,84
-0,95
-0,63
Interest and investment income
1,37 млн
1,16 млн
912,00 миң
1,89 млн
Interest expense
-
-
-
-
Net interest expenses
1,37 млн
1,16 млн
912,00 миң
1,89 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-22,24 млн
-21,27 млн
-23,76 млн
-26,20 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору